| Literature DB >> 34032161 |
Jiawei Qin1,2, Kaize Zhao3, Yannan Chen1, Shuai Guo1, Yue You1, Jinjin Xie1, Ying Xu1,4,5, Jingsong Wu1,4,5, Zhizhen Liu1,4,5, Jia Huang1,4,5, Li Dian Chen1,4,5, Jing Tao1,4,5.
Abstract
The effect of exercise intervention on balance capacity among type 2 diabetes mellitus (T2DM) patients has not been evaluated. The objective of this systematic review and meta-analysis is to investigate the effect of exercise intervention on balance capacity among T2DM patients compared to the control group (usual care, waitlist, no-treatment, education). We conducted a comprehensive literature search through PubMed, EMBASE, Physiotherapy Evidence Database (PEDro), Cochrane library, Web of Science (WOS) from inception to August 2020. The literature language was limited to English. Randomized controlled trials (RCTs) or quasi-experimental (Q-E) trials that examined the effect of exercise intervention on balance capacity among T2DM patients were included. We used the standard methods of meta-analysis to evaluate the outcomes of exercise intervention for balance capacity of T2DM patients. A total of 14 trials (11 RCTs and 3 Q-E trials) involving 883 participants were eligible. The meta-analysis of some studies demonstrated that exercise intervention could significantly improve Berg Balance Scale (BBS) (MD = 2.56; 95%CI [0.35, 4.77]; P = .02), SLST (Single Leg Stance Test) under the eyes-open (EO) condition (MD = 3.63; 95%CI [1.79, 5.47]; P = .0001) and eyes-close (EC) condition (MD = 0.41; 95%CI [0.10, 0.72]; P = .01) compared to control group. There was no significant difference in Time Up and Go Test (TUGT) (MD = -0.75; 95%CI [-1.69, 0.19]; P = .12) and fall efficacy (SMD = -0.44; 95%CI [-0.86, -0.01]; P = .05). Narrative review of some studies indicated that exercise intervention could improve postural stability measured by Sensory Organization Test (SOT) and Center of Pressure (COP) variables, etc. This systematic review and meta-analysis summarized that exercise intervention could improve balance capacity in T2DM patients. However, further studies with high quality are required to evaluate its effect.Entities:
Keywords: balance; exercise; systematic review; type 2 diabetes mellitus
Year: 2021 PMID: 34032161 PMCID: PMC8155768 DOI: 10.1177/00469580211018284
Source DB: PubMed Journal: Inquiry ISSN: 0046-9580 Impact factor: 1.730
Figure 1.Flow diagram for studies selection.
Characteristics of Including Studies.
| Authors | Countries | Study design | Participants; Diabetes duration | Sample size (female) | Age (years) | Intervention group | Control group | Outcome | Attrition | AE |
|---|---|---|---|---|---|---|---|---|---|---|
| Cai et al[ | China | Q-E | T2DM; IG:4.93 (2.29)y | IG:27 (14) | IG:64.54 (4.1) | Kinect-based Kaimai-style Qigong exercised, 3 sessions/week, 30 min/session, 12 weeks. | Waitlist | BBS | IG:0 | NR |
| CG:5.54 (3.25)y | CG:28 (17) | CG:64.51 (3.1) | CG:3 | |||||||
| Venkataraman et al[ | Singapore | RCT | T2DM with DPN; 15.3 (10.7)y | IG:70 (34) | 62 | Home-based strength and balance training, 1 session/week, 8 weeks; encourage participants to perform exercise 3 to 7 sessions/week, and a median of 25 sessions during 8 weeks. | Routine care | TUGT, FRT, ABC, Body sway velocity | IG:5 | NR |
| CG:73 (46) | CG:9 | |||||||||
| Schmid et al[ | USA | RCT | T2DM with chronic pain | IG:9 (5) | IG:56.6 (9.62) | Yoga intervention, 2 sessions/week, 8 weeks. | Usual care | FAB | IG:1 | NR |
| CG:9 (7) | CG:53.3 (11) | CG:1 | ||||||||
| Ng et al[ | China | Q-E | T2DM; IG:10.2 (8.7)y | IG:48 (35) | IG:71.4 (7.9) | Community-based exercise and daily home exercise program focusing on ankle strengthening by applying an elastic Theraband. 60 min/session, 2 sessions/week, 10 weeks. | No treatment | SOT, TUGT, SLST | IG:2 | NR |
| CG:10.2 (7.3)y | CG:45 (33) | CG:72.8 (6.5) | CG:2 | |||||||
| Hsieh et al[ | China | RCT | T2DM; IG:11.1 (7.8)y | IG:15 (10) | IG:70.6 (4.2) | Eight resistance training exercises, the progression of exercise intensity was set at a goal of 75% 1-RM or 14 to 16 on the Borg scale from 40% to 50% 1-RM or 12 to 13 on the Borg scale, 8 to 12 repetitions/set, 3 set/day, 3 days/week, 12 weeks. | Usual care | TUGT | IG:1 | NR |
| CG:13.9 (6.7)y | CG:15 (9) | CG:71.8 (4.5) | CG:1 | |||||||
| Dixit et al[ | Kingdom of Saudi Arabia | RCT | T2DM with DPN; IG:49.77 (4.72)m | IG:36 | IG:54.40 (1.24) | Moderate-intensity treadmill exercises of 40% to 60% of heart reserve, 3 to 6 sessions/week, 8 weeks, 150 to 360 min/weeks. | Usual care | COP variables | IG:8 | NR |
| CG:83.71 (3.21)m | CG:46 | CG:59.45 (1.16) | CG:10 | |||||||
| Xiao and Zhuang[ | China | RCT | T2DM | IG:16 | 65.5 | Tai chi ball exercise, 1 to 2 h/session, 3 sessions/week, 12 weeks. | No treatment | TUGT, BBS | NR | NR |
| CG:16 | ||||||||||
| Park and Lee[ | Korea | T2DM | IG:24 (13) | IG:71.2 (3.9) | Exercise including cardiovascular warm-up with stretching of the main muscle groups; combined exercise consisting of strengthening exercise and aerobic exercise; and the final cooling down phase for general relaxation and stretching of the trained muscle groups, 1 h/session, 3 sessions/week, 12 weeks. | No treatment | 8FUG, LOS | IG:15 | NR | |
| CG:13 (7) | CG:69.6 (3.6) | CG:25 | ||||||||
| Grewal et al[ | USA | RCT | T2DM with DPN; IG:17.17 ± 10.08y | IG:19 (11) | IG:62.58 ± 7.98 | Sensor-based interactive exercise training tailored for people with diabetes, focusing on shifting weight and crossing virtual obstacles. 45 min/session, 2 sessions/week, 4 weeks. | Usual care | COM sway, FES-I | IG:1 | NR |
| CG:17.40 ± 9.42y | CG:16 (8) | CG:64.90 ± 8.50 | CG:4 | |||||||
| Lee and Shin[ | Korea | RCT | T2DM; IG:10.07 (7.6)y | IG:27 (20) | IG:73.78 (4.77) | Virtual reality exercise, 50 min/session, 2 sessions/week, 10 weeks. | Health education | SLST, BBS, FRT, TUGT, MFES | IG:5 | NR |
| CG:9.04 (7.7)y | CG:28 (19) | CG:74.29 (5.20) | CG:4 | |||||||
| Ahn et al[ | Korea | Q-E | T2DM with DPN; IG:12.3 (8.81)y | IG:20 (8) | IG:66.05 (6.42) | Tai Chi for diabetes program, 60 min/session, 2 sessions/week, 12 weeks. | Usual care | SLST | IG:10 | NR |
| CG:13.0 (10.03)y | CG:19 (11) | CG:62.73 (7.53) | CG:10 | |||||||
| Kruse et al[ | USA | RCT | T2DM with DPN | IG:41 (20) | IG:66.3 (10.6) | Part 1(1-3 month) included leg strengthening and balance exercises and a graduated, self-monitored walking program; part 2 (4-12 moth) included motivational telephone calls to enhance exercise. | Health education | BBS, FES, SLST, TUGT | 5 | NR |
| CG:38 (20) | CG:64.8 (9.4) | |||||||||
| Allet et al[ | Switzerland | RCT | T2DM | IG:35 | IG:63 (7.99) | Physiotherapeutic group training including gait and balance exercises with function orientated strengthening, 60 min/session, 2 sessions/week, 12 weeks | No treatment | POMA balance, FES-I, Crossing beam, sway index | IG:5 | NR |
| CG:36 | CG:64 (8.89) | CG:8 | ||||||||
| Tsang et al[ | Australia | RCT | T2DM; IG:8.5y | IG:18 (16) | IG:66 (8) | Supervised “Tai Chi for diabetes” exercise, a ‘hybrid’ form of 12 movements from Sun and Yang Tai Chi styles, 60 min/session, 2 sessions/week, 16 weeks. | Sham exercise | Balance index, SLST, Tandem walk score | IG:1 | YES |
| CG:9.0y | CG:20 (14) | CG:65 (8) | CG:0 |
Note. IG = intervention group; CG = control group; RCT = randomized controlled trial; Q-E = Quasi-experimental trial; y = year; m = month; T2DM = type 2 diabetes mellitus; DPN = diabetic peripheral neuropath; RM = resistance maximum; BBS = Berg balance scale; TUGT = time up and go; FRT = functional reach test; ABC = activity-specific balance confidence; FAB = Fullerton advanced balance scale; SOT = sensory organization test; SLST = single leg stance test; 8FUG = 8-foot up and go; LOS = limits of stability; CoM = center of mass; COP = center of pressure; FES-I = fall efficacy scale-international; MFES = modified fall efficacy scale; FES = fall efficacy scale; POMA = Tinetti performance oriented mobility assessment; AE = adverse events; NR = not reported.
PEDro Score for Methodological Quality Assessment of Including Studies.
| Reference | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Venkataraman et al[ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Cai et al [ | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Schmid et al[ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 5/10 |
| Ng et al[ | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Hsieh et al[ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7/10 |
| Dixit et al[ | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5/10 |
| Xiao and Zhuang[ | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Park and Lee[ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 6/10 |
| Grewal et al[ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7/10 |
| Lee and Shin[ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Ahn and Song[ | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3/10 |
| Kruse et al[ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8/10 |
| Allet et al[ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8/10 |
| Tsang et al[ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7/10 |
Note. Item 1 = eligibility criteria; Item 2 = random allocation; Item 3 = concealed allocation; Item 4 = similar baseline; Item 5 = subjected blinded; Item 6 = therapists blinded; Item 7 = assessors blinded; Item 8 = <15% dropouts; Item 9 = intention-to-treat analysis; Item 10 = between-group comparison; Item 11 = point measures and variability data; 1 = described explicitly and in details; 0 = unclear, inadequately described.
Figure 2.Forest plot of the effect of exercise intervention on TUGT.
Figure 3.Forest plot of the effect of exercise intervention on BBS.
Figure 4.Forest plot of the effect of exercise intervention on SLST under EO and EC conditions.
Figure 5.Forest plot of the effect of exercise intervention on fall efficacy.
Effect of Exercise Intervention on Other Balance Capacity Assessment Tools.
| Study | Outcome measures | Intervention group post-pre mean difference (SD) | Control group post-pre mean difference (SD) | Between group mean difference (95% CI),
| Summary of results |
|---|---|---|---|---|---|
| Venkataraman et al[ | FRT(cm) | NR | NR | 0.19 [−1.59, 1.97], | There were no significant improvements in FRT performance and body sway velocity between 2 groups. |
| Body sway velocity (mm/s) | NR | NR | 0.19 [−0.01, 0.39], | ||
| Schmid et al[ | FAB | 5.84 (13.78) | −5.2 (12.02) | 11.04 [−0.91, 22.99], | There were no significant improvements in FAB between 2 groups. |
| Ng et al[ | SOT | Significant improvements were noted in Conditions 4 and 5 of the SOT (i.e., visual and vestibular ratios and the composite score). | |||
| Condition 1 | 0.7 (4.9) | −0.6 (2.3) | 1.3 [−0.24, 2.84], | ||
| Condition 2 | −0.4 (2.2) | −0.2 (3.2) | −0.20 [−1.32, 0.92], | ||
| Condition 3 | 0.8 (3.6) | 0.5 (5.1) | 0.30 [−1.50, 2.10], | ||
| Condition 4 | 5.4 (8.6) | 0.1 (8.1) | 5.30 [1.91, 8.69], | ||
| Condition 5 | 10.9 (12.9) | −0.2 (9.5) | 11.10 [6.52, 15.68], | ||
| Condition 6 | 5.3 (15.1) | 0.8 (11.0) | 4.50 [−0.85, 9.85], | ||
| Composite score | 4.6 (6.6) | 0.1 (4.9) | 4.50 [2.15, 6.85], | ||
| Somatosensory ratio | −0.01 (0.1) | 0.004 (0.04) | −0.01 [−0.04, 0.02], | ||
| Visual ratio | 0.1 (0.1) | 0.006 (0.08) | 0.09 [0.06, 0.13], | ||
| Vestibular ratio | 0.1 (0.1) | 0.002 (0.1) | 0.10 [0.06, 0.14], | ||
| Dixit et al[ | COP variables | In the EO condition, there were significant differences observed in the comparison of sway velocity along the x-axis and VM. | |||
| EO | |||||
| along x-axis (mm/s) | −0.11 (1.59) | 0.86 (1.61) | −0.97 [−1.76, −0.18], | ||
| along y-axis (mm/s) | 0.07 (1.17) | 0.06 (1.16) | 0.01 [−0.57, 0.59], | In the ECF condition, there were significant differences observed in the comparison of sway velocity along the x-axis | |
| VM (mm2/s) | 11.12 (1.82) | 15.93 (1.8) | −4.81 [−5.70, −3.92], | ||
| AP displacement (mm/s) | −0.1 (1.28) | −0.16 (1.24) | 0.06 [−0.56, 0.68], | ||
| ML displacement (mm/s) | 0.04 (1.23) | −0.08 (1.24) | 0.12 [−0.49, 0.73], | ||
| EC | |||||
| along x-axis (mm/s) | −2.4 (1.58) | −2.05 (1.57) | −0.35 [−1.13, 0.43], | ||
| along y-axis (mm/s) | 0.05 (1.23) | 0.07 (1.18) | −0.02 [−0.62, 0.58], | ||
| VM (mm2/s) | 0.23 (1.53) | 0.18 (1.44) | 0.05 [−0.69, 0.79], | ||
| AP displacement (mm/s) | 0 (1.31) | −0.15 (1.32) | 0.15 [−0.50, 0.80], | ||
| ML displacement (mm/s) | 4.04 (1.62) | 3.73 (1.55) | 0.31 [−0.48, 1.10], | ||
| EOF | |||||
| along x-axis (mm/s) | −0.14 (1.21) | 0 (1.23) | −0.14 [−0.74, 0.46], | ||
| along y-axis (mm/s) | 0.06 (1.19) | −0.08 (1.17) | 0.14 [−0.44, 0.72], | ||
| VM (mm2/s) | 0.05 (1.35) | −0.13 (1.36) | 0.18 [−0.49, 0.85], | ||
| AP displacement (mm/s) | −0.04 (1.35) | −0.03 (1.31) | −0.01 [−0.67, 0.65], | ||
| ML displacement (mm/s) | 0.28 (1.47) | 0.11 (1.55) | 0.17 [−0.57, 0.91], | ||
| ECF | |||||
| along x-axis (mm/s) | 5.92 (1.59) | 6.81 (1.49) | −0.89 [−1.65, −0.13], | ||
| along y-axis (mm/s) | 0.12 (1.20) | 0.11 (1.22) | 0.01 [−0.59, 0.61], | ||
| VM (mm2/s) | 0.21 (1.35) | 0.66 (1.37) | −0.45 [−1.12, 0.22], | ||
| AP displacement (mm/s) | −0.15 (1.34) | −0.26 (1.47) | 0.11 [−0.58, 0.80], | ||
| ML displacement (mm/s) | 0.04 (1.56) | −0.48 (1.58) | 0.52 [−0.25, 1.29], | ||
| Park and Lee[ | LOS (mm2) | 2692 (2600.89) | 128.7 (2786.9) | 2563.30 [845.31, 4281.29], | There were significant improvements in LOS and 8FUG between 2 groups. |
| 8FUG (s) | −1.1 (0.72) | 0.1 (1.15) | −1.20 [−1.84, −0.56], | ||
| Grewal et al[ | EO | N = 19 | N = 16 | Compared with the control group, the patients in the exercise intervention group showed a significantly reduced CoM sway, CoM ML sway, ankle sway and hip joint sway during the balance test with open eyes. | |
| CoM sway, cm2 | −2.14 (2.59) | −0.17 (1.47) | −1.97 [−3.34, −0.60], | ||
| CoM AP sway, cm | −0.42 (0.9) | −0.07 (0.52) | −0.35 [−0.83, 0.13], | ||
| CoM ML sway, cm | −0.76 (0.77) | −0.03 (0.55) | −0.73 [−1.17, −0.29], | ||
| Ankle sway, degree2 | −1.16 (1.61) | −0.13 (0.98) | −1.03 [−1.90, −0.16], | ||
| Hip sway, degree2 | −1.81 (4.32) | 0.24 (0.68) | −2.05 [−4.02, −0.08], | ||
| EC | |||||
| CoM sway, cm2 | −5.09 (10.05) | −0.65 (4.05) | −4.44 [−9.38, 0.50], | ||
| CoM AP sway, cm | −0.79 (1.59) | −0.02 (1) | −0.77 [−1.64, 0.10], | ||
| CoM ML sway, cm | −1 (1.17) | −0.41 (1.07) | −0.59 [−1.33, 0.15], | ||
| Ankle sway, degree2 | −1.77 (3.3) | −0.79 (3.14) | −0.98 [−3.12, 1.16], | ||
| Hip sway, degree2 | −1.81 (3.77) | −0.01 (2.04) | −1.80 [−3.77, 0.17], | ||
| Lee and Shin[ | FRT (cm) | 4.28 (6.6) | 0.6 (2.66) | 3.68 [1.00, 6.36], | Statistically significant differences were observed for the FRT scores on the pre- and post-tests between 2 groups. |
| Allet et al[ | Crossing beam (s) | −2.68 (4.89) | 0.97 (4.68) | −3.65 [−5.88, −1.42], | Crossing beam, POMA balance and Biodex sway index showed significant between- group differences in favor of the intervention group. |
| POMA balance | 1.4 (1.5) | −0.5 (1.63) | 1.90 [1.17, 2.63] ], | ||
| Biodex level 6 (SI) | −2.23 (2.25) | −0.01 (2.78) | −2.22 [−3.39, −1.05], | ||
| Biodex level 8 (SI) | −1.35 (1.89) | 0.14 (1.98) | −1.49 [−2.39, −0.59], | ||
| Tsang et al[ | Tandem walk score | −1 (7.73) | −1.3 (6.25) | 0.30 [−4.28, 4.88], | No significant changes between groups were observed in the tandem walk score and balance index. |
| Balance index | −3.8 (23.1) | −7.4 (22.2) | 3.60 [−11.07, 18.27], | ||
Note. SD = standard deviation; CI = confidence interval; FRT = functional reach test; FAB = Fullerton advanced balance scale; SOT = sensory organization test; Condition 1 = eyes open with fixed support surface; Condition 2 = eyes closed with fixed support surface; Condition 3 = sway-referenced vision with fixed support surface; Condition 4 = eyes open with sway-referenced support surface; Condition 5 = eyes closed with sway- referenced support surface; Condition 6 = sway-referenced vision with sway-referenced support surface; COP = center of pressure; EO = eyes open; EC = eyes closed; EOF = eyes open on a foam surface; ECF = eyes closed on a foam surface; VM = velocity moment; AP = anterior-posterior; ML = medial-lateral; LOS = limits of stability; 8FUG = 8-foot up and go; CoM = center of mass; POMA = Tinetti performance oriented mobility assessment; SI = sway index.
Subgroup Analysis for the Effect of Exercise Intervention on Balance Capacity.
| Outcome | Subgroup | Studies | Participants | Statistical method | Effect estimate |
|---|---|---|---|---|---|
| TUGT | DM duration ≥10 years | 3 | 178 | Mean difference (IV, Random, 95% CI) | −1 [−2.43, 0.43] |
| DM duration <10 years | 0 | 0 | Mean difference (IV, Random, 95% CI) | 0 | |
| Age ≥70 years | 3 | 178 | Mean difference (IV, Random, 95% CI) | −1 [−2.43, 0.43] | |
| Age < 70 years | 2 | 111 | Mean difference (IV, Random, 95% CI) | −0.24 [−1.25, 0.77] | |
| Female portion ≥70% | 2 | 148 | Mean difference (IV, Random, 95% CI) | −1.21 [−3.37, 0.96] | |
| Female portion <70% | 2 | 108 | Mean difference (IV, Random, 95% CI) | −0.1 [−1.09, 0.88] | |
| DM with DPN | 1 | 41 | Mean difference (IV, Random, 95% CI) | 0.1 [−1.11, 1.31] | |
| DM without DPN | 4 | 210 | Mean difference (IV, Random, 95% CI) | −1.01 [−2.08, 0.07] | |
| BBS | DM duration ≥10 years | 1 | 55 | Mean difference (IV, Random, 95% CI) | 1.89 [0.55, 3.23] |
| DM duration <10 years | 1 | 55 | Mean difference (IV, Random, 95% CI) | 4.14 [2.42, 5.86] | |
| Age ≥70 years | 1 | 55 | Mean difference (IV, Random, 95% CI) | 1.89 [0.55, 3.23] | |
| Age <70 years | 3 | 166 | Mean difference (IV, Random, 95% CI) | 3.28 [−0.45, 7.00] | |
| Female portion ≥70% | 1 | 55 | Mean difference (IV, Random, 95% CI) | 1.89 [0.55, 3.23] | |
| Female portion <70% | 2 | 134 | Mean difference (IV, Random, 95% CI) | 2.12 [−1.74, 5.98] | |
| DM with DPN | 1 | 79 | Mean difference (IV, Random, 95% CI) | 0.2 [−1.01, 1.41] | |
| DM without DPN | 3 | 142 | Mean difference (IV, Random, 95% CI) | 3.54 [1.14, 5.94] | |
| OLST (EO) | DM duration ≥10 years | 2 | 148 | Mean difference (IV, Fixed, 95% CI) | 4.43 [1.30, 7.55] |
| DM duration <10 years | 1 | 37 | Mean difference (IV, Fixed, 95% CI) | −0.9 [−7.39, 5.59] | |
| Age ≥70 years | 2 | 148 | Mean difference (IV, Fixed, 95% CI) | 4.43 [1.30, 7.55] | |
| Age <70 years | 2 | 116 | Mean difference (IV, Fixed, 95% CI) | 0.4 [0.09, 0.71] | |
| Female portion ≥70% | 2 | 148 | Mean difference (IV, Fixed, 95% CI) | 4.43 [1.30, 7.55] | |
| Female portion <70% | 2 | 116 | Mean difference (IV, Fixed, 95% CI) | 0.4 [0.09, 0.71] | |
| DM with DPN | 1 | 79 | Mean difference (IV, Fixed, 95% CI) | 0.4 [0.09, 0.71] | |
| DM without DPN | 3 | 185 | Mean difference (IV, Fixed, 95% CI) | 4.29 [1.36, 7.21] | |
| OLST (EC) | DM duration ≥10 years | 1 | 39 | Mean difference (IV, Fixed, 95% CI) | 9.09 [0.48, 17.7] |
| DM duration <10 years | 1 | 37 | Mean difference (IV, Fixed, 95% CI) | −0.9 [−7.39, 5.59] | |
| Age ≥70 years | 0 | 0 | Mean difference (IV, Fixed, 95% CI) | 0 | |
| Age <70 years | 3 | 165 | Mean difference (IV, Fixed, 95% CI) | 0.41 [0.1, 0.72] | |
| Female portion ≥70% | 1 | 37 | Mean difference (IV, Random, 95% CI) | 3.3 [−4.99, 11.59] | |
| Female portion <70% | 2 | 118 | Mean difference (IV, Random, 95% CI) | 3.64 [−4.6, 11.87] | |
| DM with DPN | 2 | 118 | Mean difference (IV, Random, 95% CI) | 3.64 [−4.6, 11.87] | |
| DM without DPN | 1 | 37 | Mean difference (IV, Random, 95% CI) | 3.3 [−4.99, 11.59] | |
| FE | DM duration ≥10 years | 2 | 90 | Std. Mean difference (IV, Fixed, 95% CI) | −0.64 [−1.07, −0.22] |
| DM duration <10 years | 0 | 0 | Std. Mean difference (IV, Fixed, 95% CI) | 0 | |
| Age ≥70 years | 1 | 55 | Std. Mean difference (IV, Fixed, 95% CI) | −0.75 [−1.11, −0.39] | |
| Age < 70 years | 3 | 185 | Std. Mean difference (IV, Fixed, 95% CI) | −0.27 [−0.56, 0.02] | |
| Female portion ≥70% | 1 | 55 | Std. Mean difference (IV, Fixed, 95% CI) | −0.75 [−1.11, −0.39] | |
| Female portion <70% | 2 | 114 | Std. Mean difference (IV, Fixed, 95% CI) | −0.06 [−0.43, 0.3] | |
| DM with DPN | 2 | 114 | Std. Mean difference (IV, Fixed, 95% CI) | −0.06 [−0.43, 0.3] | |
| DM without DPN | 2 | 126 | Std. Mean difference (IV, Fixed, 95% CI) | −0.75 [−1.11, −0.39] |
Note. DM = diabetes mellitus; DPN = diabetic peripheral neuropath; TUGT = time up and go; BBS = Berg balance scale; OLST = one leg standing test; EO = eye open; EC = eye closed; FE = fall efficacy; CI = confidence interval.